Drugs / NV1020
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00012155 | Oct 2000 → Nov 2002 | colorectal cancer, metastatic malignant neoplasm | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00149396 | Jul 2004 → Oct 2008 | colorectal cancer, liver and intrahepatic bile duct neoplasm | MediGene | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NV1020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00012155 ↗ |
| Route | Other | “single intrahepatic arterial injection” NCT00012155 ↗ |